- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Burzynski Research Institute Inc+ Add to Watchlist
BZYR:US0.1300 USD 0.0100 8.33%
As of 17:10:00 ET on 12/24/2014.
Company Profile for Burzynski Research Institute Inc (BZYR)
Burzynski Research Institute, Inc. manufactures medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids. The Company is conducting clinical trials of Antineoplastons relating to the treatment of cancer. Burzynski is seeking Food and Drug Administration approval for the sale of Antineoplastons.
Burzynski Research Institute Inc
Key Executives for Burzynski Research Institute Inc (BZYR)
|Stanislaw R BurzynskiChairman/President||Tomasz JanickiVP:Clinical Trials|
|Patryk P GoscianskiTreasurer/Secretary|